Inactive Instrument

Emergent Biosolutions Inc Share Price CINNOBER BOAT

Equities

0IGA

US29089Q1058

Pharmaceuticals

Sales 2024 * 1.02B 79.95B Sales 2025 * 1.14B 89.59B Capitalization 291M 22.9B
Net income 2024 * -155M -12.2B Net income 2025 * -110M -8.66B EV / Sales 2024 * 0.4 x
Net Debt 2024 * 111M 8.76B Net Debt 2025 * 336M 26.46B EV / Sales 2025 * 0.55 x
P/E ratio 2024 *
-1.85 x
P/E ratio 2025 *
-2.64 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.65%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 68 02-20
Director of Finance/CFO 70 25/03/18
Chief Tech/Sci/R&D Officer - 16/03/23
Members of the board TitleAgeSince
Director/Board Member 52 31/03/22
Director/Board Member 61 31/05/10
Director/Board Member 90 31/12/04
More insiders
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.
Related indices
More about the company